Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Lack of Visibility vs. No Settlement

Lack of Visibility vs. No Settlement

posted on Dec 19, 2007 10:12AM

I think the market has tanked for two simple reasons. First, because we're an OTC stock, the institutional base that often stablilizes and supports share price is missing. Secondly, without visibility as to the income PTSC gets from the last 7 licenses, the more than 150% rise from recent lows in the 40 cent range is difficult to support.

From PTSC's perspective, what's more important, settle and get good cash now and accept a very restrictive confidentiality agreement, or continue to fight in court and spend money, and perhaps get good/great cash later or perhaps not.

Not a difficult decsion IMO, but certainly the commentary lock-down causes market unease due to lack of visibility. While that may hurt the share price, it doesn't hurt the company. On the other hand, settlement with cash flow, elimination of litigation, and ability to move forward with M&A strategy certainly HELPS the company.

Stay tuned. Rome wasn't built in a day.

Share
New Message
Please login to post a reply